In The Spotlight


nasdaq-jun27.jpg Shares of BridgeBio Pharma Inc. are expected to begin trading on the Nasdaq Global Select Market today (June 27, 2019), under the ticker symbol "BBIO".

pharma-032117_24jun19.jpg Shares of CEL-SCI Corporation (CVM), which have been hitting new highs, are up over 940 percent from their 52 week low of $0.82 recorded on August 7, 2018.

ipo-jun14.jpg As another week comes to a close, let's take a look at the biotech companies that are going public in the week ahead.

ipo-jun14.jpg The IPO activity in the U.S. pharma/biotech sector has had a strong showing so far this year, with 32 listings till the end of May. Although the first half of June witnessed no IPO activity in the healthcare sector, the second half is going to be busy, and 5 companies are making their public debut in the week ahead.

vp-jun12.jpg Shares of Verrica Pharmaceuticals Inc. (VRCA) are up 12 percent year-to-date while the iShares Nasdaq Biotechnology ETF (IBB), a bellwether of investor sentiment, has gained only 8 percent for the same period.

savara-jun03.jpg The clinical trials can make or break drug companies as their stock price reaction can either be overwhelmingly positive or brutal depending upon the trial results.

moleculartemplates-may28.jpg It has been a banner year so far for Molecular Templates Inc. (MTEM), whose shares gained a whooping 102 percent year-to-date.

Follow RTT